Here, we tested if calcium signaling pathway inhibition could have an impact on Mcl-1 expression in chemoresistant ovarian carcinoma cells and we evaluated the impact of its combination with anti-Bcl-xL strategies. The gene discussed is BCL2L1; the disease is ovarian carcinoma.